Elbasvir/grazoprevir in Asia‐Pacific/Russian participants with chronic hepatitis C virus genotype 1, 4, or 6 infection

Jacob George, Eduard Burnevich, I‐Shyan Sheen, Jeong Heo, Nguyen Van Kinh, Tawesak Tanwandee, Pin‐Nan Cheng, Do Young Kim, Won Young Tak, Svetlana Kizhlo, Konstantin Zhdanov, Vasily Isakov, Liwen Liang, Pauline Lindore, Joy Ginanni, Bach‐Yen Nguyen, Janice Wahl, Eliav Barr, Michael Robertson, Paul Ingravallo, Rohit Talwani, on behalf of the C‐CORAL Study Investigators – 4 April 2018 – The prevalence of hepatitis C virus (HCV) infection in Asian countries is high.

Elbasvir/grazoprevir in Asia‐Pacific/Russian participants with chronic hepatitis C virus genotype 1, 4, or 6 infection

Jacob George, Eduard Burnevich, I‐Shyan Sheen, Jeong Heo, Nguyen Van Kinh, Tawesak Tanwandee, Pin‐Nan Cheng, Do Young Kim, Won Young Tak, Svetlana Kizhlo, Konstantin Zhdanov, Vasily Isakov, Liwen Liang, Pauline Lindore, Joy Ginanni, Bach‐Yen Nguyen, Janice Wahl, Eliav Barr, Michael Robertson, Paul Ingravallo, Rohit Talwani, on behalf of the C‐CORAL Study Investigators – 4 April 2018 – The prevalence of hepatitis C virus (HCV) infection in Asian countries is high.

Reframing the approach to patients with hepatocellular carcinoma: Longitudinal assessment with hazard associated with liver transplantation for HCC (HALTHCC) improves ablate and wait strategy

Daniel J. Firl, Shoko Kimura, John McVey, Koji Hashimoto, Heidi Yeh, Charles M. Miller, James F. Markmann, Kazunari Sasaki, Federico N. Aucejo – 31 March 2018 – Patients with hepatocellular carcinoma (HCC) are screened at presentation for appropriateness of liver transplantation (LT) using morphometric criteria, which poorly specifies risk. Morphology is the crux of measuring tumor response to locoregional therapy (LRT) using modified Response Evaluation Criteria in Solid Tumors (mRECIST).

Expanding the donor pool: Donation after circulatory death and living liver donation do not compromise the results of liver transplantation

Dagmar Kollmann, Gonzalo Sapisochin, Nicolas Goldaracena, Bettina E. Hansen, Ramraj Rajakumar, Nazia Selzner, Mamatha Bhat, Stuart McCluskey, Mark S. Cattral, Paul D. Greig, Les Lilly, Ian D. McGilvray, Anand Ghanekar, David R. Grant, Markus Selzner – 31 March 2018 – Because of the shortfall between the number of patients listed for liver transplantation (LT) and the available grafts, strategies to expand the donor pool have been developed.

Subscribe to